{"ticker": {"uuid": "e6a96f2d-1f29-46d8-a1e2-57c92ab8ff92", "symbol": "DGX", "name": "Quest Diagnostics Incorporated", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Quest Diagnostics stock trades steadily as investors weigh recent revenue growth and dividend income", "summary": "Quest Diagnostics stock reflects steady fundamentals, with investors focusing on recent revenue trends, earnings resilience, and cash returns via dividends alongside the broader US healthcare diagnostics sector. The company's financials show moderate revenue growth, stable earnin", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/quest-diagnostics-stock-trades-steadily-as-investors-weigh-recent-revenue/69824410", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-21T16:13:44", "published_display": "21 Jul 2026 16:13", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DGX4807226 Bond Coupon Profile \u2014 Rate & Payments", "summary": "This article provides the coupon profile for the DGX4807226 bond issued by Quest Diagnostics Incorporated. It details that the current coupon rate is 4.20% and the next payment is scheduled for December 31, 2026. The article highlights the bond's interest payment overview and off", "url": "https://www.tradingview.com/symbols/FINRA-DGX4807226/profile-coupon/", "source_name": "TradingView", "published_at": "2026-07-21T10:07:40", "published_display": "21 Jul 2026 10:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock trades steadily as diagnostics demand supports earnings and cash flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNUUpkR2h0T0JuSHFUUDc0M0doWDd6bmpVOFFGMk5jaGlNY2hGcGo1VDVvbTRueG4xUkpWUE1LREhqSHg0dzRhZGktZExmeHgzdUFnUUlwdU9waVRkUEs3QU1EQW9jcUdLNHBNZzBnUVN6cFotb3FMeUFaSEs5VmExeWZFLWtpbVh1MTZIdGhNdWlfenhhbXBwNEllWlhkZ05OWlRLVUVQR1B5bnZLdmI2aTZlUXl4Q2ZfczRnVzZ1TllXeUlrN0ZJbEZHaw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-21T05:17:08+00:00", "published_display": "21 Jul 2026 05:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Inc. stock underperforms Monday when compared to competitors", "summary": "Shares of Quest Diagnostics Inc. (DGX) fell 1.43% on Monday, closing at $207.66. This underperformance occurred on a generally negative trading day, with both the S&P 500 Index and Dow Jones Industrial Average also declining. The stock's drop ended a two-day winning streak.", "url": "https://www.marketwatch.com/data-news/quest-diagnostics-inc-stock-underperforms-monday-when-compared-to-competitors-b3897e27-5eea342b7be6?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-20T20:37:32", "published_display": "20 Jul 2026 20:37", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tempus to buy cancer test-maker Personalis for $1.5B", "summary": "Tempus AI has announced an agreement to acquire Personalis, a maker of molecular residual disease tests for cancer, for $1.5 billion. This acquisition is expected to enhance Tempus's capabilities in cancer diagnostics, treatment selection, recurrence, and monitoring, building on ", "url": "https://www.medtechdive.com/news/tempus-to-buy-cancer-test-maker-personalis-for-15b/825684/", "source_name": "MedTech Dive", "published_at": "2026-07-20T19:09:17", "published_display": "20 Jul 2026 19:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Q2 2026 Earnings Preview \u2014 July 23, Street Expects $2.82 EPS", "summary": "Wall Street anticipates Quest Diagnostics will report Q2 2026 earnings of $2.82 per share on revenue of $2.97 billion, with the announcement expected on July 23. This projection reflects a 7.6% increase in both EPS and revenue compared to Q2 2025 results. Analysts will be closely", "url": "https://news.alphastreet.com/quest-diagnostics-q2-2026-earnings-preview-july-23-street-expects-2-82-eps/", "source_name": "AlphaStreet", "published_at": "2026-07-20T13:37:34", "published_display": "20 Jul 2026 13:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock trades steady as investors weigh recent earnings and diagnostics demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOY2lWQW5SZGVnT0ZmTkxpMTJ1YUx2ai1jYWFiWkRrZzBXZ056bzBnQzhjczF1OXp4YjM0cGJjNGxweDJsXzA0OFpBbGRHd3hHeU1NdlRUcTUycWI3WlVpZ3JZMk1yeGlFTnpwQnRZSHR3MGNKQ25yRkF0Zy1CYS0zRmJrbnM4UHJKMHREWV9QZU04Slh1eHItME5vRW1EaTctN3d4bHJiYjFyOENwWTY1QXlZT292cnV3cmdiMnJUM1lSdw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-20T11:16:28+00:00", "published_display": "20 Jul 2026 11:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IDEXX Laboratories stock stays anchored to its diagnostics growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQTGtXazQ2emZha2llSjlaYldkV01VdWhuc3htd1BRQ3B2OVNQTzJxTEktT2hKdFdMNDhxRWVlV0ZkY0dmRHhHOFh0X0xXOU9WcGx5UEFRS2JGLUtHTWluOXVWSEplLUpTOC1zQzlNWDNpcEVUdnA4ZDFlbU1UTC03cHVQdDg2cHlteFE4RmxKc3A2MHhldzNZVHF6ZlJxOTUtNklORkYtRURkT1dPTTM3UHdzMXhuSTV5aGIyTW81WmpUZw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-20T10:50:44+00:00", "published_display": "20 Jul 2026 10:50", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics stock trades steady as investors weigh recent earnings and volume trends", "summary": "Quest Diagnostics stock is trading steadily as investors assess its recent earnings and volume trends, driven by diagnostic testing demand and margin performance. The company's financial health is supported by resilient testing volumes, cost-management initiatives, strong cash fl", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/quest-diagnostics-stock-trades-steady-as-investors-weigh-recent-earnings/69811607", "source_name": "ad-hoc-news.de", "published_at": "2026-07-20T09:44:40", "published_display": "20 Jul 2026 09:44", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics (DGX) Expands Oncology Test Access, Is The Stock Fully Valued?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-20T01:04:35+00:00", "published_display": "20 Jul 2026 01:04", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics | SCHEDULE 13G/A: Others", "summary": "This article is a financial filing document, specifically a SCHEDULE 13G/A, related to Quest Diagnostics. The \"Others\" designation suggests a filing by a category of investor other than an institutional manager, perhaps an individual or a passive investor group revealing benefici", "url": "https://www.moomoo.com/news/notice/306774281/quest-diagnostics-schedule-13g-a-others", "source_name": "Moomoo", "published_at": "2026-07-19T08:07:31", "published_display": "19 Jul 2026 08:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock trades steady as diagnostics demand supports earnings and cash flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQeEE2NXcxNFlzM2VhVkZjX3lMajV3QzNVd1V2d3dXMllRUzVNa2RHbzVhcEZueEpnZFpyYXNKOU9ZZzdtOXdzMVZoRUV0bEd1MVFJYkJKSzAzSjdaajdVUi1TR1RfZmJrNDIydWI2R2dlRU1jdmU5NmV6dDNwZ3pWdG1BRTNHZjVabTdtUzNpckNCX2V5VVIteVkwVzZfMmJNVlNTZy1Tb2t2M0dEZDM3TmoxaGlkZ2lvX1RQWWZZYk9PVjJMNXFzSQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-19T01:57:24+00:00", "published_display": "19 Jul 2026 01:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DGX4986719 Bond Risk Profile", "summary": "This article provides a risk profile for the Quest Diagnostics Incorporated 2.8% bond, identified as DGX4986719. It highlights key metrics for assessing credit risk, such as security level, inflation protection, and issuer rating. The profile aims to help investors evaluate the b", "url": "https://www.tradingview.com/symbols/FINRA-DGX4986719/profile-risks/", "source_name": "TradingView", "published_at": "2026-07-18T19:07:25", "published_display": "18 Jul 2026 19:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For Quest Diagnostics (DGX) Could Change Following Oncology Test Integration Into OncoEMR - Learn Why", "summary": "Quest Diagnostics recently integrated its Haystack MRD ctDNA test and Comprehensive Genomic Profiling services into Flatiron Health\u2019s OncoEMR, granting 4,700 clinicians easier access to these oncology tests. This move positions Quest as the largest reference lab to integrate adva", "url": "https://www.sahmcapital.com/news/content/the-bull-case-for-quest-diagnostics-dgx-could-change-following-oncology-test-integration-into-oncoemr-learn-why-2026-07-17", "source_name": "Sahm", "published_at": "2026-07-18T04:08:37", "published_display": "18 Jul 2026 04:08", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics stock holds near results driven levels", "summary": "Quest Diagnostics stock performance is being evaluated based on its recent earnings metrics, including quarterly revenue of $2.62 billion, adjusted diluted EPS of $2.64, and an adjusted operating margin of 15.0%. The company's core diagnostic testing franchise is its primary earn", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/quest-diagnostics-stock-holds-near-results-driven-levels/69791351", "source_name": "ad-hoc-news.de", "published_at": "2026-07-18T03:02:31", "published_display": "18 Jul 2026 03:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Quest Diagnostics Incorporated Stocks", "summary": "This article lists various Exchange Traded Funds (ETFs) that hold Quest Diagnostics Incorporated (DGX) stocks. It provides a detailed table including each fund's market value, weight", "url": "https://www.tradingview.com/symbols/BMV-DGX/etfs/", "source_name": "TradingView", "published_at": "2026-07-17T07:07:34", "published_display": "17 Jul 2026 07:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics stock trades steadily as investors weigh steady revenue and margin trends", "summary": "Quest Diagnostics stock reflects a balance between stable revenue growth and margin pressures. Recent financial results show the company managing the transition from pandemic-related testing to routine services, maintaining mid-single-digit revenue growth and mid-teens operating ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/quest-diagnostics-stock-trades-steadily-as-investors-weigh-steady-revenue/69784174", "source_name": "Ad Hoc News", "published_at": "2026-07-17T03:33:36", "published_display": "17 Jul 2026 03:33", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Quest Diagnostics Inc (DGX) Overvalued After 3.8% Rally? GF V", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxOTFlPbE9JQ2tPMGhEczlVcDgwcl95X1htcnJnQkNjc0l5aHlpZjgzUlNzQV92NWdRaHpudWFPNzVoUUlaNVItc29xNzBUNHBEcVFUdEhvU3VIV3dtZEs4Wi1nV2VNa2FPRG5pZzZmNWtPXzVKUTlQMlpqRFBjRDJ4WlVtVU9ycW82TDdRX2xjWVY2ZFRuM2ZJR0lPQjBrbFFoeDJPRmlNR1NoX1ZrbzFuR1MtR3M3R05kc1JydUVVc0FUYkMxVVR6STBDQWotRVFvMjloYW5kSm9LV1c0eFFSbURhZzRCZEtKUnRpUXlqbw?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T22:49:27+00:00", "published_display": "16 Jul 2026 22:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Inc. stock outperforms competitors on strong trading day", "summary": "Quest Diagnostics Inc. (DGX) shares rose 3.79% to $209.41 on Thursday, outperforming the broader market which saw the S&P 500 Index fall 0.51% and the Dow Jones Industrial Average decline 0.20%. This gain broke a nine-day losing streak for the company's stock.", "url": "https://www.marketwatch.com/data-news/quest-diagnostics-inc-stock-outperforms-competitors-on-strong-trading-day-71c788d1-3fdbee0bf566?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-16T22:37:35", "published_display": "16 Jul 2026 22:37", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DGX.GL Bond Profile \u2014 Key Metrics", "summary": "This article provides key metrics for the DGX.GL bond, issued by Quest Diagnostics, Inc. The bond has a 5.75% coupon rate and matures on January 30, 2040, with an outstanding amount of $249.24 million. Quest Diagnostics, Inc. is a diagnostic testing and information services compa", "url": "https://www.tradingview.com/symbols/FINRA-DGX.GL/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-16T14:37:49", "published_display": "16 Jul 2026 14:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Stock In Shambles: Down 6.2% With 9-Day Losing Streak", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxOQ1JjNmM5QVZTZks2Um5ZcjFMWkdyZEd1ejR2UDNJZEpwZFFYWmNuWkV3SUd1V0lPZDR1X2JybnVFeHQwNmhGYXhjU0NZbkF3NFBISDB5SEE2NTRnWXZvcklEZnpTQjVOLWJGRjNHNkJwZVhOTk5sa0ZnZlBYQ2xaeUR4ZEVlNG9CbHphMWdsYjhLQ055UkRwQVcxMy1nMkNIQ1Jmbng3YkZJZTlGZ1liQXlPc0UyN3lzMjJPWk4tcENLQnplSXBKQ21WaGlUSmozS2Nkcg?oc=5", "source_name": "Trefis", "published_at": "2026-07-16T12:32:54+00:00", "published_display": "16 Jul 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A 9-Day Losing Streak Has Quest Diagnostics Stock Down 6.2%", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOTmFqLUxfNHQ4SkNqMmdJdnhYRFR0a1BlUVBJTXVYNy1HVU9OWF9rQVNZQkhXbVVEbEZSNDBhNWphazN6cVBUY1FRa2JhMDA3SUFuWV9acE1BWkNpekVhanlRU1g1eHlueG5BM1Q4NVA2M1RvRGthSWo4MFYycTdMSDlsVjJZRzlzSkhpM0NMWDNmSWZJMktFaWM1STI1ZGR4djRYWXJrRllmVzhOaGpfWGtTdWZLS2FOTmc?oc=5", "source_name": "Trefis", "published_at": "2026-07-16T11:20:55+00:00", "published_display": "16 Jul 2026 11:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics stock holds steady as diagnostics demand underpins long term growth", "summary": "Quest Diagnostics stock reflects the company's significant position as a major US clinical laboratory operator, benefiting from a steady, long-term demand for diagnostic services. The company's large-scale network, operational efficiency, and role in chronic disease management an", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/quest-diagnostics-stock-holds-steady-as-diagnostics-demand-underpins-long/69779446", "source_name": "Ad Hoc News", "published_at": "2026-07-16T11:58:38", "published_display": "16 Jul 2026 11:58", "sentiment": "positive", "sentiment_pct": 77, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors", "summary": "Shares of Quest Diagnostics Inc. (DGX) fell 2.05% on Wednesday, closing at $201.77. This underperformance occurred despite a favorable trading session for the broader market, with both the S&P 500 Index and the Dow Jones Industrial Average posting gains. This marked the ninth con", "url": "https://www.marketwatch.com/data-news/quest-diagnostics-inc-stock-underperforms-wednesday-when-compared-to-competitors-e8ced96b-92951eb14980", "source_name": "MarketWatch", "published_at": "2026-07-15T17:03:00", "published_display": "15 Jul 2026 17:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Leerink Partners Adjusts Quest Diagnostics Price Target to $244 From $240, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/leerink-partners-adjusts-quest-diagnostics-160239361.html", "source_name": "MT Newswires", "published_at": "2026-07-15T16:02:39+00:00", "published_display": "15 Jul 2026 16:02", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Currently Down Nine Consecutive Days, on Pace for Longest Losing Streak Since September 2001 -- Data Talk", "summary": "Quest Diagnostics (DGX) has experienced a nine-day losing streak, its longest since September 2001, and is currently trading down 0.7% at $139.12. Despite this recent downturn, the stock has seen a 1-month gain of 0.77%, but a 6-month loss of 1.13%, and is down 2.87% year-to-date", "url": "https://www.moomoo.com/news/post/73018830/quest-diagnostics-currently-down-nine-consecutive-days-on-pace-for?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-15T14:37:37", "published_display": "15 Jul 2026 14:37", "sentiment": "negative", "sentiment_pct": 26, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A4ET8Q Bond Profile \u2014 Key Metrics", "summary": "This article provides key metrics for the A4ET8Q bond, issued by Quest Diagnostics, Inc. The bond has a 5.0% coupon rate, an issue date of May 6, 2026, and matures on June 30, 2036. Quest Diagnostics, Inc. specializes in diagnostic testing and information services through its Dia", "url": "https://www.tradingview.com/symbols/GETTEX-A4ET8Q/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-15T12:08:43", "published_display": "15 Jul 2026 12:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Quest Diagnostics (DGX) and Gilead Sciences (GILD)", "summary": "Three analysts from Bank of America Securities have provided bullish sentiments on healthcare companies Medtronic (MDT), Quest Diagnostics (DGX), and Gilead Sciences (GILD). Travis Steed maintained a Buy rating on Medtronic with a $95.00 price target, Michael Ryskin kept a Buy ra", "url": "https://www.theglobeandmail.com/investing/markets/stocks/DGX/pressreleases/3268979/analysts-offer-insights-on-healthcare-companies-medtronic-mdt-quest-diagnostics-dgx-and-gilead-sciences-gild/", "source_name": "The Globe and Mail", "published_at": "2026-07-15T04:37:42", "published_display": "15 Jul 2026 04:37", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US74834LBG4 Bond Profile \u2014 Key Metrics", "summary": "This article provides a detailed profile of the Quest Diagnostics Incorporated 5.0% 15-DEC-2034 bond, identified by the ISIN US74834LBG4. Key metrics such as issue date, maturity date, outstanding amount, face value, and coupon rate are presented. It also includes a brief descrip", "url": "https://www.tradingview.com/symbols/DUS-US74834LBG4/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-14T23:37:52", "published_display": "14 Jul 2026 23:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A28XES Bond Risk Profile", "summary": "This article provides a risk profile for the A28XES bond issued by Quest Diagnostics Incorporated. It highlights key metrics for credit risk assessment, including security level, inflation protection, and issuer rating, to help investors evaluate the bond's reliability. The bond ", "url": "https://www.tradingview.com/symbols/GETTEX-A28XES/profile-risks/", "source_name": "TradingView", "published_at": "2026-07-14T16:37:43", "published_display": "14 Jul 2026 16:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics to Report Q2 Earnings: Key Customer Channels in Focus", "summary": "Quest Diagnostics is scheduled to release its second-quarter 2026 earnings on July 23, with analysts expecting revenue growth of 7.9% and an EPS increase of 7.3%. The company's performance is anticipated to be boosted by strong demand across physician, enterprise, and consumer ch", "url": "https://www.tradingview.com/news/zacks:244bf6b8d094b:0-quest-diagnostics-to-report-q2-earnings-key-customer-channels-in-focus/", "source_name": "TradingView", "published_at": "2026-07-14T14:07:35", "published_display": "14 Jul 2026 14:07", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott's Q2 Earnings on Deck: How Should You Play the Stock Now?", "summary": "Abbott Laboratories (ABT) is set to release its second-quarter 2026 results on July 16, with analysts expecting a 1.6% EPS growth and 12% revenue increase year-over-year. The company's Diagnostics, Established Pharmaceutical Products, and Medical Devices segments are anticipated ", "url": "https://www.tradingview.com/news/zacks:3bed42957094b:0-abbott-s-q2-earnings-on-deck-how-should-you-play-the-stock-now/", "source_name": "TradingView", "published_at": "2026-07-14T13:07:02", "published_display": "14 Jul 2026 13:07", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics stock holds steady on a broad health care backdrop", "summary": "Quest Diagnostics (DGX) remains a significant player in the U.S. diagnostics market, providing essential testing services to physicians, hospitals, and employers. The company's business model, which includes routine blood work and specialty diagnostics, positions it as a defensiv", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/quest-diagnostics-stock-holds-steady-on-a-broad-health-care-backdrop/69763792", "source_name": "Ad Hoc News", "published_at": "2026-07-14T04:25:41", "published_display": "14 Jul 2026 04:25", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics (DGX) Stock Analysis: Uncovering A 7.83% Upside Potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNMVVEcXp4QlpOeUNKVXJ6ZGt0ZmxFTlNaR2ZpdUJtRXhnT3BBcXl4SV9Ia1lOQjVLeTdacTdUZzRzZl8zZGhWUDROZ3dlYjRua2VzdTNQNFp4a1N1ZndRMEJrNTVPNHZ0UFFvSThHSlgycEFJNHZ3dU5XdzlFWmpWak53N0dsdUNTNEpLTHpuUndCVV9tTG1wYmRLN003YzlqMHZyTzNaWmxpMjNwY2ZsT3FGVGJpYVVqNnQ2RmxRRQ?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:08:43+00:00", "published_display": "13 Jul 2026 09:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock holds steady as diagnostics demand supports long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQYXRxTGlQaFZybjJ5a2J0WHl5bXp5QTRPMS1vTG5XVUoyU3Z4ZlRiSnUtRTQ2TWF4dG9FSzkwYmRYcnhDZUFqXzVuSTdFVEg1eVU0TXBNS2k0V2xEdm9MR3lzNTlCMzN3UEpMNmppZTlfbEZRWGloRm84VjllY0dtTUNMM3pCZFdyVUlPaS1saXdOOU1OVzVDa29zRURQZXlsRVZ6M3pITWVVSmVyQXZpSXIwWGxyaWxQZ1VNRTgwRGo4RndMZEE2MERVZlQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-13T06:08:44+00:00", "published_display": "13 Jul 2026 06:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics (NYSE:DGX) Offers a Secure and Sustainable Dividend with Strong Profitability", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQT29RaTA1YV8wM2NmMGdkOXVOSEJPRGxRcENXOXJWMjBZWWtXaU1WOHBzZHJveXNsTEtaYU51OWdvbmtqT1FHOEkyekxNX09oOEVHM3ZkRkpfaGFaMVJ0WjdTazlfd3NyMHhCa1Iyc0MtTEdQT25MSjk4S0lwS2dpc3llVVhUMVliOGFYUmlGSkRXNUt4RTBLenAtaVZqUmdRT3F4N3VSc3FRNlRsQWpLdlNrMmsyVF96WDlLS0xpTFBuTHlvVC1DVVlpX0lHNmNBcU1CQl81NDVDdlk?oc=5", "source_name": "ChartMill", "published_at": "2026-07-11T09:50:31+00:00", "published_display": "11 Jul 2026 09:50", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche stock holds steady as pharma giant leans on diagnostics and oncology strength", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPa0hsdjNPUWxBTFVtcXYyOUpSbnB0WnpoR1k5c1EyaFVPOXJmR0NROGpoazIwMC1FWFFiYmh4VGl5ZkZHbEFtNXNBalBIbTY5Q29aSXdNTkpiNEU4ZDdIZHJ2SjNoYjRqaHBLdUNSYTBieUhEdHBzc1V0UFQ3QkxPZ0s0d2pSWWhid3pOQW5uMUVHRmRpQmpCa0FkY2hrVHM4c2ViTFRWOWpLVkY2NWpBM0FuMkFDZWlUaG5ncWl4ckxNeENDMjhHWVpUSG8xUQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-11T08:31:21+00:00", "published_display": "11 Jul 2026 08:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Expands Oncology Testing Access Via Flatiron Health's OncoEMR MPI", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/quest-diagnostics-expands-oncology-testing-135326717.html", "source_name": "MT Newswires", "published_at": "2026-07-08T13:53:26+00:00", "published_display": "08 Jul 2026 13:53", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/quest-diagnostics-now-largest-clinical-125200791.html", "source_name": "PR Newswire", "published_at": "2026-07-08T12:52:00+00:00", "published_display": "08 Jul 2026 12:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics brings cancer test ordering into OncoEMR for 4,700 clinicians", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQZ0ZNajktZm5WWHpXMU14LU9paFRKTDIwUEVBNDh4SXBXOC1iTWhIaG9SZkFHbzNkWGkyU2tzaXpfSjNzWFpIelBjaHBrd3VOYnhPZzhPRHJSbVNGSWRRaVhHam5hSExERUJGaG1tSUQ0RFRsekxxZXNWNFQxbHNnOEJPOVNwNlQzbldlbFR1RkxxdXpydlVlUnp3SkNZb3lndURGTHlRZlNpOE5UTVFQNFdGdTZ6OU1MWUdVaw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics (DGX) Stock Analysis: Revenue Growth and Dividend Yield Capture Investor Attention", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxNYkVVSF9CRDFhU0s1LVZ0V0diSmdaUjB4bGd0Y0V1d2tlVVdLY2FCNjdmODBvQjBCaDRoazNuQ2RQTmtBcUFTeHdXckpzNWwwbnNpS1F1YUdqSld1Y3Rkay1SaHNPdDh5RHpQV1pyVHBsMHh1ZG5iOUo5eUE4QnE4TTFrQ1JOaXQ5RmduVVF4d3dtZWE0WExvRy1JdU95RmZocjMwUElOZUUzcHI2RlRVNmZEYklLR1o4a2lONDFBRDlucUNXQk1fQ3JuSnRxS2k5QkJOR3psNlFFWUhOUGszZ2Zn?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-06T09:16:18+00:00", "published_display": "06 Jul 2026 09:16", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics (DGX) Could Be 4% Undervalued On Haystack MRD Approval", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/quest-diagnostics-incorporated-dgx-hits-131502369.html", "source_name": "Zacks", "published_at": "2026-07-02T13:15:02+00:00", "published_display": "02 Jul 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fund Update: 111,974 QUEST DIAGNOSTICS (DGX) shares added to EASTERN BANK portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNTVF4OTNLZjlCRjdDaE9Oa2xyb1dQWXA2VUVXTnpTSFVueHQ2TC1LSmU5TC1CaDlPY1RockNBelphREJHbUxqZVFQSjZFSHVZQ21CZ1pZUWxiVEt6Rlp2NjJvQzJMMjZHcGdKajFEb0dUNEp6aF9FWWMxaW1lcHlpdGxyd0kySGctbG9ZZXR5Z2V0MW5rRUNiQmMtSnhhNVFPd3Q0T3RRU3Q2WTNuZ2NDVVFxM0dvRlcyOFpqdGFDdzFJdw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. updates earnings calendar, shares tracked against diagnostics peers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOUTNqbEpUTW4xd3RUTE5nMEt0ZEJFT25xZVBoYjRYYk56b18xdkwyWFJncVR1cjMwa25pbUhudWk2Ukk5RlBqLU1fRXo5YmZXNlZQMG5ubnExM1o4YXZpSDE3enY4T0MtLTVIS1dnYUlVWTZMNW5HVkFKNVFFbFZRVnQ3Z0ZkNnJmN0NMRHVRZXJtQkw2b1RUazZSZW1yaTVCM0VVYU9RM1o3YWF4MHlZM2ppSWZnekVxUEN4Y01GaWRiUXVTMHE0bXRB?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-26T05:11:57+00:00", "published_display": "26 Jun 2026 05:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Testing & Diagnostics Services Stocks\u2019 Q1 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxPUDVFLS1zeGZLMm45ZW50dUNiTWZjREFfWjhySVZHSk5oUmcwdWRidlJuNVNlOW95WXI1Z1N4eUpaYTVuSmV1LW1wZ0tRVHV1WGRGV2xCN1BxOGFOTzQxMXpwSW54Mko4SWpwb3dYeldMUFk0LWdyOU9lU29QblNQOUJ2cnRaNlkyQWZCRmRra1dzbjQ5X3VJN0tqNUx0M1dJSm5fa2syNVpRYzhhNFliMW1lUXVGVHVHRGtvV3RHd2tXTFJCTjVfcFVfX0w3eTRMNTNrWXdvSThiTnhkRllPOG5aamx2Y2VlLVZpaUJ1MEdVM0xVakdXdWxzdWgyclE?oc=5", "source_name": "StockStory", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Quest Diagnostics stock rallying today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPbXFXNjVpNjUzOEZEdWlVeVdQdmJBVTZOdjA4QVE3YW5DQjJ2UFpPYU45SVVoSHh1WjNQZm5JX00tLVh3TmV3Mk1ueGdwRXplVmpkSFB2Zm9nV2Q2YnV1dmN6eXVmcTllODd3SW04UVNQOGdUU2MzVTVIMFc1S1dob0ZqZXpERmI3VkJnakxWVDlwTG5LRUxINzVXZnFJQWcyOHZtWXdWYi1jNUU?oc=5", "source_name": "Investing.com", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New York clears Quest Diagnostics' cancer recurrence test statewide", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPYnljTWJHQjV2ZDluWlRDSzlaRlFsRzVGTlpSdVpKeDhRYWo3M1ExcG91WExDV0c0ald0QXdfZ19YU284YzdhVkdwZV9EZDBabjlnRVFfZjZuVW1TVndfaEVwYkR5R0NVRThzYS11dXVfOENkQ181VHh3c3kxa0Mxcmc2bC1fcTE1NXVqRjhLLWtrNDlQejJRT1Z2ZEtwa2drQXl0MUpVNmhyRnl3SkFyZDZrVWZTWHVZMmw3MGRn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Receives New York State Approval for Haystack MRD\u00ae, Broadening Patient Access to ctDNA Minimal Residual Disease Testing", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwJBVV95cUxOZUxCOFpfZk9YU2Zfb283OHpDMjF5U3dxZUVHbW5xV1VYN285c1h1ZGhNNkJtS2xkM3hGZmRDNEtINW96MG5lVnVBcFVtX3ZORjl6c3RkcWQ5OVNDOG9YTDdiN2pkSUxkTTg0eHpfRHo3SWdnM1gteXhkV3BCVElKNjJHTVo5b3BSMlFGOFpHeXlDTnNXX3lKVHQyeEVHck10bUpEdmVQQzM2ZDc0c05RYkZpb0E0a1BwaFBIWEpuVjMwdkoySWpMa0VQOExHanVxWTFrekk5QlNwWjBDQVdpZXlYbmI2X2xuYVRtUnVxaHdva3BkLUYtLUV5aDVnMEp1alk1ZTZoa2tlZHl5eFp2LXY0eWxMYWIyaUV3?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is it Apt to Hold Quest Diagnostics Stock in Your Portfolio Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPaDBvclM5dmxLTzV4YjRkZXkzMWo5Q1Q1Q2hxQ1VKNkY1UUtsdDhQemJpbzdWaFFOU3dPcE5OR3daVGRTbXMwNFByUjRkOTc3MXNXb1NtLVNtUXNzVjd6N0MtM3F3bDcwM005dWs4LVhPSlA1ODVpRFpDNExyY0tVUGRQaW5uVnFKcGhvWE16blFFNzkxLVBOX3d0R2E2QQ?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Stock - Analyst targets, sector review and weekly recap", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxONXVEeDZuTjZDaXh0dnlqY0NPTENZX0c4cFBxSDV3UWh1NC1XMU9ialR4Wk5TbnlpRVpXU05EVENEYjAtcGpoZmR2TVhLandUM0tIS2V4Rmk0dDZJMk44bm9tbl9SRUwtcGNLOXBGOGp4WlNpeE1aY0ZwRDdEZzB2NDhhUXFCV0p1MFB2djBnaDdfREtqMmhHcTFFMHIwcy1qOURxR2c2QTQzTkNsczZqbklmb0h2WlE5OE51cUlZU0VyY2ZMeUpHVw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-19T16:09:41+00:00", "published_display": "19 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Quest Diagnostics Stock Underperforming the S&P 500?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZzVHaGpYWlJ4N2ZQUFVyWXRJQ2hoRHdNM0ROb0RTTkhkelQ2RjJULU94R01fNkRMbTROXzR6VU10cndMbVpQMzZsVWExcWFRMXhiYno2OUs3U1o2T1ZnS2RlRkZycW93U083Q3B1V3VXd2RyOU80U2hRMEdmUEFwTVdKcHhQMWstaHBJdUYzLVFRTFhqS2l2RVFWR2ZUZ2wxMFQ3eC1NSGptZw?oc=5", "source_name": "Market source", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$21M in discounted Quest lab tests, aid for firefighters and cancer cluster", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOT3M0QWpLQ3A4SGRnTXNZVnZ3OFJ3YjlkV0ljZE44R182a0hqT0kwcmhpVnZhdDFsVE1PekY3Znp4QTJ1c1ZPSDd0UzZpREM3VlJsREZiTmp0cUN2cktYWkpRUEo0aVdUQ25LanJlYjNadEFJeW5pTEhJSXM1TGVSYmVmVVpGYWlqM0NvSjNDdjFsdzFEQ3VBcHB6NzFfdlVGczI3aVZpSmtUNjdQY3ItY0l6WkxDVXFlNk1xSmhQNA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics (DGX) Stock Analysis: Strong Upside Potential With Analyst Consensus", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQVUJtRmhiaDR3aGk1emdqZ25JYWszWWNxMFVuVDhsMk1EZ0s2M01sWGNzM0hSTzQ1RmdOa1dDRl9XS3kzZXRGUjJoejRtYlJQRzVteDlQSE1xczNraWVITVRVajFId0ZlRGdzZzhfMC1rMjFMbTlTU21sWldvMnlFWFlSWi00c2cwTzdpU2R1M1hWUWs1cGxXdWl4RnAzekdrYkp2cHVLSnJvMzd2eTNrSDBYa1ZkVUEtTGhiZ0ItN25iRXlUMGZIZ1UtQnR2Z1k?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Quest Diagnostics (DGX) Investment Story Is Evolving Without New Analyst Price Target Changes", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQY0VuaXVJNXNMMk9rYkxGNzBQbkpPdzZtdWU2ZkU1dmRVNkhmNnYtZDJzUlZZVnBGMFAyY2Z4eTBuR19lUjNjZkRUamZCYVFXTEEwU1hXdnJ2QVFsblZCQWdvMEhtNHlJS1JqcDFPM2ZOOTBDQW1tTkxTNzdqT0lQd0NCeWRocmFIajkwTk5DZS1hTVFQYlZ5Wi12cTd5SVkybHA2R05B?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQR0h2TXFURlJLTUIxUFdNTFA2ZkRhOTg2TDFsLXk2WDlqeTlBdmR4aE82SmZkWVJqamc4UThwSTQwVVRyOFYtQ1ZENmt6UTNVNFVHeW5BTEl0ZTFRUHBVZ00zb2xjQ0RHTFRvMkxUWnJHQkk5a1hmZ2Uycm1MY1NENzZIWGlKbzM5SmJxSm53YWJLWFliZ19DMWREMm1IR181NzZGaE11c3M?oc=5", "source_name": "Market source", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Quest Diagnostics (DGX) Down 5% Since Last Earnings Report?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPN0xSNFI0RU5JaFg2VkoybVZTRWc2YlJTSE5CXzJiUEd1MElRS2hOOTRJc2hHOGxTSWl2X2JUZnBnc21kN1FqSWlBOERtcy1IYVROcnJ4UEhweUFRN0ZsVF9yNVM2TnVyZFowRVdFak5KQkJqSmZTMy1tZ1QycDFXdER6SFl2OHZtQUNvajlicjFkdTVxN1Z4d28tbw?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Declares Quarterly Cash Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNQ1RMRWdmY2FkallFQWpWYy1GMkE0MzZ1dVIzcEFOTm52SDVaUldTNU54ZjZwLXJNOVJFd20zeTR4R1g1ZmdYX0dKcFJvMDJXakgzS1RyNTdlYmJrQ0hXREpXMzJxWnB0R29KS0ZvRVg1bXdvaVU1czY2eklac3JBbDhXYWNERzBVNW5Nc3ZzOUFnMHRRbkxNcEJIN0JubF95VWN5MjVOSDhndw?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_gFBVV95cUxQRDZaS1ZUNEhZMnNxcGZzeW5zTGVzUFplSFA4VVpJUW1SOXZsX09UUW5jQkJEMWVrSVVFSGZUU1hLOUpwMXBTNkx4cG9iaUJtd2hhd0dxbGFOa0xkNUEtaWJ3bEdvcWd2RFJLY1NwbDdqUTc0WWFUSDdtYTh0ZkZuUHpOQWJ4U05Xa2tsMEs4cFZVajYxT19YczgzRWEwdGtmLWxFMWNTQ3oxTWVuT1FUakhyR19Vbmd2cGEtMVMxZHM3amJlYWcxS1hkYW0xcGNua1hzb09iMUxYVHpjU3FST085dWRGc1dHeUc5dXhoRjg5MWJvMVZkOUx4dWxZZw?oc=5", "source_name": "PR Newswire", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Investment Story For Quest Diagnostics (DGX) Is Quietly Shifting Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNMU5JeWttcFBpZk85Rl9kbXpYM1hKTWwwbXZwQ3g2Nm1Jamg5QldGMWxBUDJmdXJxbWRkUkpDY09HM3VDWGE3Y0pXMk4zVU9qX2NibHBESl9UZHdGYW52NkpnYVpfbHhmZkhFandpdGR2TGRhVndKRWVvenhxdmVfWjF1MXhCdTd0M3pxSDE4a0JKLWRZejU4RHJyN2x2QWdERlhLNmhR?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Quest Diagnostics stock trades steadily as investors weigh recent revenue growth and dividend income", "summary": "Quest Diagnostics stock reflects steady fundamentals, with investors focusing on recent revenue trends, earnings resilience, and cash returns via dividends alongside the broader US healthcare diagnostics sector. The company's financials show moderate revenue growth, stable earnin", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/quest-diagnostics-stock-trades-steadily-as-investors-weigh-recent-revenue/69824410", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-21T16:13:44", "published_display": "21 Jul 2026 16:13", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DGX4807226 Bond Coupon Profile \u2014 Rate & Payments", "summary": "This article provides the coupon profile for the DGX4807226 bond issued by Quest Diagnostics Incorporated. It details that the current coupon rate is 4.20% and the next payment is scheduled for December 31, 2026. The article highlights the bond's interest payment overview and off", "url": "https://www.tradingview.com/symbols/FINRA-DGX4807226/profile-coupon/", "source_name": "TradingView", "published_at": "2026-07-21T10:07:40", "published_display": "21 Jul 2026 10:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock trades steadily as diagnostics demand supports earnings and cash flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNUUpkR2h0T0JuSHFUUDc0M0doWDd6bmpVOFFGMk5jaGlNY2hGcGo1VDVvbTRueG4xUkpWUE1LREhqSHg0dzRhZGktZExmeHgzdUFnUUlwdU9waVRkUEs3QU1EQW9jcUdLNHBNZzBnUVN6cFotb3FMeUFaSEs5VmExeWZFLWtpbVh1MTZIdGhNdWlfenhhbXBwNEllWlhkZ05OWlRLVUVQR1B5bnZLdmI2aTZlUXl4Q2ZfczRnVzZ1TllXeUlrN0ZJbEZHaw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-21T05:17:08+00:00", "published_display": "21 Jul 2026 05:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Inc. stock underperforms Monday when compared to competitors", "summary": "Shares of Quest Diagnostics Inc. (DGX) fell 1.43% on Monday, closing at $207.66. This underperformance occurred on a generally negative trading day, with both the S&P 500 Index and Dow Jones Industrial Average also declining. The stock's drop ended a two-day winning streak.", "url": "https://www.marketwatch.com/data-news/quest-diagnostics-inc-stock-underperforms-monday-when-compared-to-competitors-b3897e27-5eea342b7be6?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-20T20:37:32", "published_display": "20 Jul 2026 20:37", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tempus to buy cancer test-maker Personalis for $1.5B", "summary": "Tempus AI has announced an agreement to acquire Personalis, a maker of molecular residual disease tests for cancer, for $1.5 billion. This acquisition is expected to enhance Tempus's capabilities in cancer diagnostics, treatment selection, recurrence, and monitoring, building on ", "url": "https://www.medtechdive.com/news/tempus-to-buy-cancer-test-maker-personalis-for-15b/825684/", "source_name": "MedTech Dive", "published_at": "2026-07-20T19:09:17", "published_display": "20 Jul 2026 19:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Q2 2026 Earnings Preview \u2014 July 23, Street Expects $2.82 EPS", "summary": "Wall Street anticipates Quest Diagnostics will report Q2 2026 earnings of $2.82 per share on revenue of $2.97 billion, with the announcement expected on July 23. This projection reflects a 7.6% increase in both EPS and revenue compared to Q2 2025 results. Analysts will be closely", "url": "https://news.alphastreet.com/quest-diagnostics-q2-2026-earnings-preview-july-23-street-expects-2-82-eps/", "source_name": "AlphaStreet", "published_at": "2026-07-20T13:37:34", "published_display": "20 Jul 2026 13:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock trades steady as investors weigh recent earnings and diagnostics demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOY2lWQW5SZGVnT0ZmTkxpMTJ1YUx2ai1jYWFiWkRrZzBXZ056bzBnQzhjczF1OXp4YjM0cGJjNGxweDJsXzA0OFpBbGRHd3hHeU1NdlRUcTUycWI3WlVpZ3JZMk1yeGlFTnpwQnRZSHR3MGNKQ25yRkF0Zy1CYS0zRmJrbnM4UHJKMHREWV9QZU04Slh1eHItME5vRW1EaTctN3d4bHJiYjFyOENwWTY1QXlZT292cnV3cmdiMnJUM1lSdw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-20T11:16:28+00:00", "published_display": "20 Jul 2026 11:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IDEXX Laboratories stock stays anchored to its diagnostics growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQTGtXazQ2emZha2llSjlaYldkV01VdWhuc3htd1BRQ3B2OVNQTzJxTEktT2hKdFdMNDhxRWVlV0ZkY0dmRHhHOFh0X0xXOU9WcGx5UEFRS2JGLUtHTWluOXVWSEplLUpTOC1zQzlNWDNpcEVUdnA4ZDFlbU1UTC03cHVQdDg2cHlteFE4RmxKc3A2MHhldzNZVHF6ZlJxOTUtNklORkYtRURkT1dPTTM3UHdzMXhuSTV5aGIyTW81WmpUZw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-20T10:50:44+00:00", "published_display": "20 Jul 2026 10:50", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics stock trades steady as investors weigh recent earnings and volume trends", "summary": "Quest Diagnostics stock is trading steadily as investors assess its recent earnings and volume trends, driven by diagnostic testing demand and margin performance. The company's financial health is supported by resilient testing volumes, cost-management initiatives, strong cash fl", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/quest-diagnostics-stock-trades-steady-as-investors-weigh-recent-earnings/69811607", "source_name": "ad-hoc-news.de", "published_at": "2026-07-20T09:44:40", "published_display": "20 Jul 2026 09:44", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics (DGX) Expands Oncology Test Access, Is The Stock Fully Valued?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxQRTFNUnJrNHZlNjVudlJCaWpuWnNSMUFTZ0pXNm9qVFVhVTlxTlFrQzMzMldtbmxXMl9UanJrYVk0LWFGdktRb1RFbHVXYkJaZ0xMX2dCM2JqSklEQkRHY3NfUUhQaC1qakM5MmlfS05HSkl6NTZOMUVsZjlDdkxScUEyNUEwQ2hKUHREc1Q3V0RsRnViemxjaU5JdjZVdVVwX3ltOU9IYzFhMS1uRDhHNEtSODFMaC1oa3puZUczeDVwdnZvMGhqdTByS1FFbmIt0gHWAUFVX3lxTE5iaGdjR3pvS09uMVV2Y2JGTGxEVU1yZ0R5OHlQcjZ1aHBJc1ZxWnpza0VsNS1aY3k2VGZ3bmdjbVZDdVFWeUJoSkdlRnV0VkphdzFBeWlNczEzcmxUUEtJM0szcG5VSEZlWXJDUkFRR2F0c2RuUTg4M1k0aF9XSTREQkpDb3U5czE3MjF0bkhMZnU2Wk1ITm9teW1YRG1WcmhMUHFoVlI4QURSYUk5ZzdDbGw4QlRCZThlSFhGRHh2blNtN1RNanpyc2NaOExVdGpqS3hkbnc?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-20T01:04:35+00:00", "published_display": "20 Jul 2026 01:04", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics | SCHEDULE 13G/A: Others", "summary": "This article is a financial filing document, specifically a SCHEDULE 13G/A, related to Quest Diagnostics. The \"Others\" designation suggests a filing by a category of investor other than an institutional manager, perhaps an individual or a passive investor group revealing benefici", "url": "https://www.moomoo.com/news/notice/306774281/quest-diagnostics-schedule-13g-a-others", "source_name": "Moomoo", "published_at": "2026-07-19T08:07:31", "published_display": "19 Jul 2026 08:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock trades steady as diagnostics demand supports earnings and cash flow", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQeEE2NXcxNFlzM2VhVkZjX3lMajV3QzNVd1V2d3dXMllRUzVNa2RHbzVhcEZueEpnZFpyYXNKOU9ZZzdtOXdzMVZoRUV0bEd1MVFJYkJKSzAzSjdaajdVUi1TR1RfZmJrNDIydWI2R2dlRU1jdmU5NmV6dDNwZ3pWdG1BRTNHZjVabTdtUzNpckNCX2V5VVIteVkwVzZfMmJNVlNTZy1Tb2t2M0dEZDM3TmoxaGlkZ2lvX1RQWWZZYk9PVjJMNXFzSQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-19T01:57:24+00:00", "published_display": "19 Jul 2026 01:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DGX4986719 Bond Risk Profile", "summary": "This article provides a risk profile for the Quest Diagnostics Incorporated 2.8% bond, identified as DGX4986719. It highlights key metrics for assessing credit risk, such as security level, inflation protection, and issuer rating. The profile aims to help investors evaluate the b", "url": "https://www.tradingview.com/symbols/FINRA-DGX4986719/profile-risks/", "source_name": "TradingView", "published_at": "2026-07-18T19:07:25", "published_display": "18 Jul 2026 19:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For Quest Diagnostics (DGX) Could Change Following Oncology Test Integration Into OncoEMR - Learn Why", "summary": "Quest Diagnostics recently integrated its Haystack MRD ctDNA test and Comprehensive Genomic Profiling services into Flatiron Health\u2019s OncoEMR, granting 4,700 clinicians easier access to these oncology tests. This move positions Quest as the largest reference lab to integrate adva", "url": "https://www.sahmcapital.com/news/content/the-bull-case-for-quest-diagnostics-dgx-could-change-following-oncology-test-integration-into-oncoemr-learn-why-2026-07-17", "source_name": "Sahm", "published_at": "2026-07-18T04:08:37", "published_display": "18 Jul 2026 04:08", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics stock holds near results driven levels", "summary": "Quest Diagnostics stock performance is being evaluated based on its recent earnings metrics, including quarterly revenue of $2.62 billion, adjusted diluted EPS of $2.64, and an adjusted operating margin of 15.0%. The company's core diagnostic testing franchise is its primary earn", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/quest-diagnostics-stock-holds-near-results-driven-levels/69791351", "source_name": "ad-hoc-news.de", "published_at": "2026-07-18T03:02:31", "published_display": "18 Jul 2026 03:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Quest Diagnostics Incorporated Stocks", "summary": "This article lists various Exchange Traded Funds (ETFs) that hold Quest Diagnostics Incorporated (DGX) stocks. It provides a detailed table including each fund's market value, weight", "url": "https://www.tradingview.com/symbols/BMV-DGX/etfs/", "source_name": "TradingView", "published_at": "2026-07-17T07:07:34", "published_display": "17 Jul 2026 07:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics stock trades steadily as investors weigh steady revenue and margin trends", "summary": "Quest Diagnostics stock reflects a balance between stable revenue growth and margin pressures. Recent financial results show the company managing the transition from pandemic-related testing to routine services, maintaining mid-single-digit revenue growth and mid-teens operating ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/quest-diagnostics-stock-trades-steadily-as-investors-weigh-steady-revenue/69784174", "source_name": "Ad Hoc News", "published_at": "2026-07-17T03:33:36", "published_display": "17 Jul 2026 03:33", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Quest Diagnostics Inc (DGX) Overvalued After 3.8% Rally? GF V", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxOTFlPbE9JQ2tPMGhEczlVcDgwcl95X1htcnJnQkNjc0l5aHlpZjgzUlNzQV92NWdRaHpudWFPNzVoUUlaNVItc29xNzBUNHBEcVFUdEhvU3VIV3dtZEs4Wi1nV2VNa2FPRG5pZzZmNWtPXzVKUTlQMlpqRFBjRDJ4WlVtVU9ycW82TDdRX2xjWVY2ZFRuM2ZJR0lPQjBrbFFoeDJPRmlNR1NoX1ZrbzFuR1MtR3M3R05kc1JydUVVc0FUYkMxVVR6STBDQWotRVFvMjloYW5kSm9LV1c0eFFSbURhZzRCZEtKUnRpUXlqbw?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T22:49:27+00:00", "published_display": "16 Jul 2026 22:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Inc. stock outperforms competitors on strong trading day", "summary": "Quest Diagnostics Inc. (DGX) shares rose 3.79% to $209.41 on Thursday, outperforming the broader market which saw the S&P 500 Index fall 0.51% and the Dow Jones Industrial Average decline 0.20%. This gain broke a nine-day losing streak for the company's stock.", "url": "https://www.marketwatch.com/data-news/quest-diagnostics-inc-stock-outperforms-competitors-on-strong-trading-day-71c788d1-3fdbee0bf566?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-16T22:37:35", "published_display": "16 Jul 2026 22:37", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DGX.GL Bond Profile \u2014 Key Metrics", "summary": "This article provides key metrics for the DGX.GL bond, issued by Quest Diagnostics, Inc. The bond has a 5.75% coupon rate and matures on January 30, 2040, with an outstanding amount of $249.24 million. Quest Diagnostics, Inc. is a diagnostic testing and information services compa", "url": "https://www.tradingview.com/symbols/FINRA-DGX.GL/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-16T14:37:49", "published_display": "16 Jul 2026 14:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Stock In Shambles: Down 6.2% With 9-Day Losing Streak", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxOQ1JjNmM5QVZTZks2Um5ZcjFMWkdyZEd1ejR2UDNJZEpwZFFYWmNuWkV3SUd1V0lPZDR1X2JybnVFeHQwNmhGYXhjU0NZbkF3NFBISDB5SEE2NTRnWXZvcklEZnpTQjVOLWJGRjNHNkJwZVhOTk5sa0ZnZlBYQ2xaeUR4ZEVlNG9CbHphMWdsYjhLQ055UkRwQVcxMy1nMkNIQ1Jmbng3YkZJZTlGZ1liQXlPc0UyN3lzMjJPWk4tcENLQnplSXBKQ21WaGlUSmozS2Nkcg?oc=5", "source_name": "Trefis", "published_at": "2026-07-16T12:32:54+00:00", "published_display": "16 Jul 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A 9-Day Losing Streak Has Quest Diagnostics Stock Down 6.2%", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOTmFqLUxfNHQ4SkNqMmdJdnhYRFR0a1BlUVBJTXVYNy1HVU9OWF9rQVNZQkhXbVVEbEZSNDBhNWphazN6cVBUY1FRa2JhMDA3SUFuWV9acE1BWkNpekVhanlRU1g1eHlueG5BM1Q4NVA2M1RvRGthSWo4MFYycTdMSDlsVjJZRzlzSkhpM0NMWDNmSWZJMktFaWM1STI1ZGR4djRYWXJrRllmVzhOaGpfWGtTdWZLS2FOTmc?oc=5", "source_name": "Trefis", "published_at": "2026-07-16T11:20:55+00:00", "published_display": "16 Jul 2026 11:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics stock holds steady as diagnostics demand underpins long term growth", "summary": "Quest Diagnostics stock reflects the company's significant position as a major US clinical laboratory operator, benefiting from a steady, long-term demand for diagnostic services. The company's large-scale network, operational efficiency, and role in chronic disease management an", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/quest-diagnostics-stock-holds-steady-as-diagnostics-demand-underpins-long/69779446", "source_name": "Ad Hoc News", "published_at": "2026-07-16T11:58:38", "published_display": "16 Jul 2026 11:58", "sentiment": "positive", "sentiment_pct": 77, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors", "summary": "Shares of Quest Diagnostics Inc. (DGX) fell 2.05% on Wednesday, closing at $201.77. This underperformance occurred despite a favorable trading session for the broader market, with both the S&P 500 Index and the Dow Jones Industrial Average posting gains. This marked the ninth con", "url": "https://www.marketwatch.com/data-news/quest-diagnostics-inc-stock-underperforms-wednesday-when-compared-to-competitors-e8ced96b-92951eb14980", "source_name": "MarketWatch", "published_at": "2026-07-15T17:03:00", "published_display": "15 Jul 2026 17:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Leerink Partners Adjusts Quest Diagnostics Price Target to $244 From $240, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/leerink-partners-adjusts-quest-diagnostics-160239361.html", "source_name": "MT Newswires", "published_at": "2026-07-15T16:02:39+00:00", "published_display": "15 Jul 2026 16:02", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Currently Down Nine Consecutive Days, on Pace for Longest Losing Streak Since September 2001 -- Data Talk", "summary": "Quest Diagnostics (DGX) has experienced a nine-day losing streak, its longest since September 2001, and is currently trading down 0.7% at $139.12. Despite this recent downturn, the stock has seen a 1-month gain of 0.77%, but a 6-month loss of 1.13%, and is down 2.87% year-to-date", "url": "https://www.moomoo.com/news/post/73018830/quest-diagnostics-currently-down-nine-consecutive-days-on-pace-for?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-15T14:37:37", "published_display": "15 Jul 2026 14:37", "sentiment": "negative", "sentiment_pct": 26, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A4ET8Q Bond Profile \u2014 Key Metrics", "summary": "This article provides key metrics for the A4ET8Q bond, issued by Quest Diagnostics, Inc. The bond has a 5.0% coupon rate, an issue date of May 6, 2026, and matures on June 30, 2036. Quest Diagnostics, Inc. specializes in diagnostic testing and information services through its Dia", "url": "https://www.tradingview.com/symbols/GETTEX-A4ET8Q/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-15T12:08:43", "published_display": "15 Jul 2026 12:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Quest Diagnostics (DGX) and Gilead Sciences (GILD)", "summary": "Three analysts from Bank of America Securities have provided bullish sentiments on healthcare companies Medtronic (MDT), Quest Diagnostics (DGX), and Gilead Sciences (GILD). Travis Steed maintained a Buy rating on Medtronic with a $95.00 price target, Michael Ryskin kept a Buy ra", "url": "https://www.theglobeandmail.com/investing/markets/stocks/DGX/pressreleases/3268979/analysts-offer-insights-on-healthcare-companies-medtronic-mdt-quest-diagnostics-dgx-and-gilead-sciences-gild/", "source_name": "The Globe and Mail", "published_at": "2026-07-15T04:37:42", "published_display": "15 Jul 2026 04:37", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US74834LBG4 Bond Profile \u2014 Key Metrics", "summary": "This article provides a detailed profile of the Quest Diagnostics Incorporated 5.0% 15-DEC-2034 bond, identified by the ISIN US74834LBG4. Key metrics such as issue date, maturity date, outstanding amount, face value, and coupon rate are presented. It also includes a brief descrip", "url": "https://www.tradingview.com/symbols/DUS-US74834LBG4/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-14T23:37:52", "published_display": "14 Jul 2026 23:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A28XES Bond Risk Profile", "summary": "This article provides a risk profile for the A28XES bond issued by Quest Diagnostics Incorporated. It highlights key metrics for credit risk assessment, including security level, inflation protection, and issuer rating, to help investors evaluate the bond's reliability. The bond ", "url": "https://www.tradingview.com/symbols/GETTEX-A28XES/profile-risks/", "source_name": "TradingView", "published_at": "2026-07-14T16:37:43", "published_display": "14 Jul 2026 16:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics to Report Q2 Earnings: Key Customer Channels in Focus", "summary": "Quest Diagnostics is scheduled to release its second-quarter 2026 earnings on July 23, with analysts expecting revenue growth of 7.9% and an EPS increase of 7.3%. The company's performance is anticipated to be boosted by strong demand across physician, enterprise, and consumer ch", "url": "https://www.tradingview.com/news/zacks:244bf6b8d094b:0-quest-diagnostics-to-report-q2-earnings-key-customer-channels-in-focus/", "source_name": "TradingView", "published_at": "2026-07-14T14:07:35", "published_display": "14 Jul 2026 14:07", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott's Q2 Earnings on Deck: How Should You Play the Stock Now?", "summary": "Abbott Laboratories (ABT) is set to release its second-quarter 2026 results on July 16, with analysts expecting a 1.6% EPS growth and 12% revenue increase year-over-year. The company's Diagnostics, Established Pharmaceutical Products, and Medical Devices segments are anticipated ", "url": "https://www.tradingview.com/news/zacks:3bed42957094b:0-abbott-s-q2-earnings-on-deck-how-should-you-play-the-stock-now/", "source_name": "TradingView", "published_at": "2026-07-14T13:07:02", "published_display": "14 Jul 2026 13:07", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics stock holds steady on a broad health care backdrop", "summary": "Quest Diagnostics (DGX) remains a significant player in the U.S. diagnostics market, providing essential testing services to physicians, hospitals, and employers. The company's business model, which includes routine blood work and specialty diagnostics, positions it as a defensiv", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/quest-diagnostics-stock-holds-steady-on-a-broad-health-care-backdrop/69763792", "source_name": "Ad Hoc News", "published_at": "2026-07-14T04:25:41", "published_display": "14 Jul 2026 04:25", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics (DGX) Stock Analysis: Uncovering A 7.83% Upside Potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNMVVEcXp4QlpOeUNKVXJ6ZGt0ZmxFTlNaR2ZpdUJtRXhnT3BBcXl4SV9Ia1lOQjVLeTdacTdUZzRzZl8zZGhWUDROZ3dlYjRua2VzdTNQNFp4a1N1ZndRMEJrNTVPNHZ0UFFvSThHSlgycEFJNHZ3dU5XdzlFWmpWak53N0dsdUNTNEpLTHpuUndCVV9tTG1wYmRLN003YzlqMHZyTzNaWmxpMjNwY2ZsT3FGVGJpYVVqNnQ2RmxRRQ?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:08:43+00:00", "published_display": "13 Jul 2026 09:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock holds steady as diagnostics demand supports long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQYXRxTGlQaFZybjJ5a2J0WHl5bXp5QTRPMS1vTG5XVUoyU3Z4ZlRiSnUtRTQ2TWF4dG9FSzkwYmRYcnhDZUFqXzVuSTdFVEg1eVU0TXBNS2k0V2xEdm9MR3lzNTlCMzN3UEpMNmppZTlfbEZRWGloRm84VjllY0dtTUNMM3pCZFdyVUlPaS1saXdOOU1OVzVDa29zRURQZXlsRVZ6M3pITWVVSmVyQXZpSXIwWGxyaWxQZ1VNRTgwRGo4RndMZEE2MERVZlQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-13T06:08:44+00:00", "published_display": "13 Jul 2026 06:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics (NYSE:DGX) Offers a Secure and Sustainable Dividend with Strong Profitability", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQT29RaTA1YV8wM2NmMGdkOXVOSEJPRGxRcENXOXJWMjBZWWtXaU1WOHBzZHJveXNsTEtaYU51OWdvbmtqT1FHOEkyekxNX09oOEVHM3ZkRkpfaGFaMVJ0WjdTazlfd3NyMHhCa1Iyc0MtTEdQT25MSjk4S0lwS2dpc3llVVhUMVliOGFYUmlGSkRXNUt4RTBLenAtaVZqUmdRT3F4N3VSc3FRNlRsQWpLdlNrMmsyVF96WDlLS0xpTFBuTHlvVC1DVVlpX0lHNmNBcU1CQl81NDVDdlk?oc=5", "source_name": "ChartMill", "published_at": "2026-07-11T09:50:31+00:00", "published_display": "11 Jul 2026 09:50", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche stock holds steady as pharma giant leans on diagnostics and oncology strength", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPa0hsdjNPUWxBTFVtcXYyOUpSbnB0WnpoR1k5c1EyaFVPOXJmR0NROGpoazIwMC1FWFFiYmh4VGl5ZkZHbEFtNXNBalBIbTY5Q29aSXdNTkpiNEU4ZDdIZHJ2SjNoYjRqaHBLdUNSYTBieUhEdHBzc1V0UFQ3QkxPZ0s0d2pSWWhid3pOQW5uMUVHRmRpQmpCa0FkY2hrVHM4c2ViTFRWOWpLVkY2NWpBM0FuMkFDZWlUaG5ncWl4ckxNeENDMjhHWVpUSG8xUQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-11T08:31:21+00:00", "published_display": "11 Jul 2026 08:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Expands Oncology Testing Access Via Flatiron Health's OncoEMR MPI", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/quest-diagnostics-expands-oncology-testing-135326717.html", "source_name": "MT Newswires", "published_at": "2026-07-08T13:53:26+00:00", "published_display": "08 Jul 2026 13:53", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/quest-diagnostics-now-largest-clinical-125200791.html", "source_name": "PR Newswire", "published_at": "2026-07-08T12:52:00+00:00", "published_display": "08 Jul 2026 12:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics brings cancer test ordering into OncoEMR for 4,700 clinicians", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQZ0ZNajktZm5WWHpXMU14LU9paFRKTDIwUEVBNDh4SXBXOC1iTWhIaG9SZkFHbzNkWGkyU2tzaXpfSjNzWFpIelBjaHBrd3VOYnhPZzhPRHJSbVNGSWRRaVhHam5hSExERUJGaG1tSUQ0RFRsekxxZXNWNFQxbHNnOEJPOVNwNlQzbldlbFR1RkxxdXpydlVlUnp3SkNZb3lndURGTHlRZlNpOE5UTVFQNFdGdTZ6OU1MWUdVaw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics (DGX) Stock Analysis: Revenue Growth and Dividend Yield Capture Investor Attention", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxNYkVVSF9CRDFhU0s1LVZ0V0diSmdaUjB4bGd0Y0V1d2tlVVdLY2FCNjdmODBvQjBCaDRoazNuQ2RQTmtBcUFTeHdXckpzNWwwbnNpS1F1YUdqSld1Y3Rkay1SaHNPdDh5RHpQV1pyVHBsMHh1ZG5iOUo5eUE4QnE4TTFrQ1JOaXQ5RmduVVF4d3dtZWE0WExvRy1JdU95RmZocjMwUElOZUUzcHI2RlRVNmZEYklLR1o4a2lONDFBRDlucUNXQk1fQ3JuSnRxS2k5QkJOR3psNlFFWUhOUGszZ2Zn?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-06T09:16:18+00:00", "published_display": "06 Jul 2026 09:16", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics (DGX) Could Be 4% Undervalued On Haystack MRD Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPMEpfbGdSeXc4ekx4dzRGN2IwZVFZYjZRSEphRlNwU0sxSXJMREVoZkVlQ045ZFNraXY0LWFjTV9RNUlyQlhoaFQyaXlTLUZ1OFBDSEE0bkVWdjg3Y0o2WVZnT0dPcFdkS1JOY19SRFdUcXlaaDRPRmQtN2ZCME9JZy1oLWFaZzVYN1Z6WU45bVhBeHFDWVhIYjc0azdjZ1VDbkVtdGdoVTctcXp6YTB0M0Y0NEdjeEgxWEs0bTQtRHNGNEk4WjAtR2xPNXdFYy1o0gHWAUFVX3lxTFA1VXBMeDh6QkcxUVFvMjVWbmZqaGhMNnM4YWtqQmJnN1dfbHFNT3JadHJ4MDMzS3BFZUNuQ05jZWV4Xy16T01zMjVNTjVyYUs3SzZ4U0dZakNKNWhQN0VHOTRNWE8zS1RhNGhVVlpOSHVmSXUxVTRZTERaTXZWd2JWZEVkblRSd1RqbnliTF9ZTXVHSmdianNmbzdEZFNiUjc5emlreWhLcnZFb0d2S21OVjdxSF9fT1ZkWmFTaUZCVGVHMmk3Xy1zc3RUMnVMb2RYSDJKaWc?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/quest-diagnostics-incorporated-dgx-hits-131502369.html", "source_name": "Zacks", "published_at": "2026-07-02T13:15:02+00:00", "published_display": "02 Jul 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fund Update: 111,974 QUEST DIAGNOSTICS (DGX) shares added to EASTERN BANK portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNTVF4OTNLZjlCRjdDaE9Oa2xyb1dQWXA2VUVXTnpTSFVueHQ2TC1LSmU5TC1CaDlPY1RockNBelphREJHbUxqZVFQSjZFSHVZQ21CZ1pZUWxiVEt6Rlp2NjJvQzJMMjZHcGdKajFEb0dUNEp6aF9FWWMxaW1lcHlpdGxyd0kySGctbG9ZZXR5Z2V0MW5rRUNiQmMtSnhhNVFPd3Q0T3RRU3Q2WTNuZ2NDVVFxM0dvRlcyOFpqdGFDdzFJdw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. updates earnings calendar, shares tracked against diagnostics peers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOUTNqbEpUTW4xd3RUTE5nMEt0ZEJFT25xZVBoYjRYYk56b18xdkwyWFJncVR1cjMwa25pbUhudWk2Ukk5RlBqLU1fRXo5YmZXNlZQMG5ubnExM1o4YXZpSDE3enY4T0MtLTVIS1dnYUlVWTZMNW5HVkFKNVFFbFZRVnQ3Z0ZkNnJmN0NMRHVRZXJtQkw2b1RUazZSZW1yaTVCM0VVYU9RM1o3YWF4MHlZM2ppSWZnekVxUEN4Y01GaWRiUXVTMHE0bXRB?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-26T05:11:57+00:00", "published_display": "26 Jun 2026 05:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Testing & Diagnostics Services Stocks\u2019 Q1 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxPUDVFLS1zeGZLMm45ZW50dUNiTWZjREFfWjhySVZHSk5oUmcwdWRidlJuNVNlOW95WXI1Z1N4eUpaYTVuSmV1LW1wZ0tRVHV1WGRGV2xCN1BxOGFOTzQxMXpwSW54Mko4SWpwb3dYeldMUFk0LWdyOU9lU29QblNQOUJ2cnRaNlkyQWZCRmRra1dzbjQ5X3VJN0tqNUx0M1dJSm5fa2syNVpRYzhhNFliMW1lUXVGVHVHRGtvV3RHd2tXTFJCTjVfcFVfX0w3eTRMNTNrWXdvSThiTnhkRllPOG5aamx2Y2VlLVZpaUJ1MEdVM0xVakdXdWxzdWgyclE?oc=5", "source_name": "StockStory", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Quest Diagnostics stock rallying today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPbXFXNjVpNjUzOEZEdWlVeVdQdmJBVTZOdjA4QVE3YW5DQjJ2UFpPYU45SVVoSHh1WjNQZm5JX00tLVh3TmV3Mk1ueGdwRXplVmpkSFB2Zm9nV2Q2YnV1dmN6eXVmcTllODd3SW04UVNQOGdUU2MzVTVIMFc1S1dob0ZqZXpERmI3VkJnakxWVDlwTG5LRUxINzVXZnFJQWcyOHZtWXdWYi1jNUU?oc=5", "source_name": "Investing.com", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New York clears Quest Diagnostics' cancer recurrence test statewide", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPYnljTWJHQjV2ZDluWlRDSzlaRlFsRzVGTlpSdVpKeDhRYWo3M1ExcG91WExDV0c0ald0QXdfZ19YU284YzdhVkdwZV9EZDBabjlnRVFfZjZuVW1TVndfaEVwYkR5R0NVRThzYS11dXVfOENkQ181VHh3c3kxa0Mxcmc2bC1fcTE1NXVqRjhLLWtrNDlQejJRT1Z2ZEtwa2drQXl0MUpVNmhyRnl3SkFyZDZrVWZTWHVZMmw3MGRn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Receives New York State Approval for Haystack MRD\u00ae, Broadening Patient Access to ctDNA Minimal Residual Disease Testing", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwJBVV95cUxOZUxCOFpfZk9YU2Zfb283OHpDMjF5U3dxZUVHbW5xV1VYN285c1h1ZGhNNkJtS2xkM3hGZmRDNEtINW96MG5lVnVBcFVtX3ZORjl6c3RkcWQ5OVNDOG9YTDdiN2pkSUxkTTg0eHpfRHo3SWdnM1gteXhkV3BCVElKNjJHTVo5b3BSMlFGOFpHeXlDTnNXX3lKVHQyeEVHck10bUpEdmVQQzM2ZDc0c05RYkZpb0E0a1BwaFBIWEpuVjMwdkoySWpMa0VQOExHanVxWTFrekk5QlNwWjBDQVdpZXlYbmI2X2xuYVRtUnVxaHdva3BkLUYtLUV5aDVnMEp1alk1ZTZoa2tlZHl5eFp2LXY0eWxMYWIyaUV3?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is it Apt to Hold Quest Diagnostics Stock in Your Portfolio Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPaDBvclM5dmxLTzV4YjRkZXkzMWo5Q1Q1Q2hxQ1VKNkY1UUtsdDhQemJpbzdWaFFOU3dPcE5OR3daVGRTbXMwNFByUjRkOTc3MXNXb1NtLVNtUXNzVjd6N0MtM3F3bDcwM005dWs4LVhPSlA1ODVpRFpDNExyY0tVUGRQaW5uVnFKcGhvWE16blFFNzkxLVBOX3d0R2E2QQ?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Stock - Analyst targets, sector review and weekly recap", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxONXVEeDZuTjZDaXh0dnlqY0NPTENZX0c4cFBxSDV3UWh1NC1XMU9ialR4Wk5TbnlpRVpXU05EVENEYjAtcGpoZmR2TVhLandUM0tIS2V4Rmk0dDZJMk44bm9tbl9SRUwtcGNLOXBGOGp4WlNpeE1aY0ZwRDdEZzB2NDhhUXFCV0p1MFB2djBnaDdfREtqMmhHcTFFMHIwcy1qOURxR2c2QTQzTkNsczZqbklmb0h2WlE5OE51cUlZU0VyY2ZMeUpHVw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-19T16:09:41+00:00", "published_display": "19 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Quest Diagnostics Stock Underperforming the S&P 500?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZzVHaGpYWlJ4N2ZQUFVyWXRJQ2hoRHdNM0ROb0RTTkhkelQ2RjJULU94R01fNkRMbTROXzR6VU10cndMbVpQMzZsVWExcWFRMXhiYno2OUs3U1o2T1ZnS2RlRkZycW93U083Q3B1V3VXd2RyOU80U2hRMEdmUEFwTVdKcHhQMWstaHBJdUYzLVFRTFhqS2l2RVFWR2ZUZ2wxMFQ3eC1NSGptZw?oc=5", "source_name": "Market source", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "$21M in discounted Quest lab tests, aid for firefighters and cancer cluster", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOT3M0QWpLQ3A4SGRnTXNZVnZ3OFJ3YjlkV0ljZE44R182a0hqT0kwcmhpVnZhdDFsVE1PekY3Znp4QTJ1c1ZPSDd0UzZpREM3VlJsREZiTmp0cUN2cktYWkpRUEo0aVdUQ25LanJlYjNadEFJeW5pTEhJSXM1TGVSYmVmVVpGYWlqM0NvSjNDdjFsdzFEQ3VBcHB6NzFfdlVGczI3aVZpSmtUNjdQY3ItY0l6WkxDVXFlNk1xSmhQNA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics (DGX) Stock Analysis: Strong Upside Potential With Analyst Consensus", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQVUJtRmhiaDR3aGk1emdqZ25JYWszWWNxMFVuVDhsMk1EZ0s2M01sWGNzM0hSTzQ1RmdOa1dDRl9XS3kzZXRGUjJoejRtYlJQRzVteDlQSE1xczNraWVITVRVajFId0ZlRGdzZzhfMC1rMjFMbTlTU21sWldvMnlFWFlSWi00c2cwTzdpU2R1M1hWUWs1cGxXdWl4RnAzekdrYkp2cHVLSnJvMzd2eTNrSDBYa1ZkVUEtTGhiZ0ItN25iRXlUMGZIZ1UtQnR2Z1k?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Quest Diagnostics (DGX) Investment Story Is Evolving Without New Analyst Price Target Changes", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQY0VuaXVJNXNMMk9rYkxGNzBQbkpPdzZtdWU2ZkU1dmRVNkhmNnYtZDJzUlZZVnBGMFAyY2Z4eTBuR19lUjNjZkRUamZCYVFXTEEwU1hXdnJ2QVFsblZCQWdvMEhtNHlJS1JqcDFPM2ZOOTBDQW1tTkxTNzdqT0lQd0NCeWRocmFIajkwTk5DZS1hTVFQYlZ5Wi12cTd5SVkybHA2R05B?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQR0h2TXFURlJLTUIxUFdNTFA2ZkRhOTg2TDFsLXk2WDlqeTlBdmR4aE82SmZkWVJqamc4UThwSTQwVVRyOFYtQ1ZENmt6UTNVNFVHeW5BTEl0ZTFRUHBVZ00zb2xjQ0RHTFRvMkxUWnJHQkk5a1hmZ2Uycm1MY1NENzZIWGlKbzM5SmJxSm53YWJLWFliZ19DMWREMm1IR181NzZGaE11c3M?oc=5", "source_name": "Market source", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Quest Diagnostics (DGX) Down 5% Since Last Earnings Report?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPN0xSNFI0RU5JaFg2VkoybVZTRWc2YlJTSE5CXzJiUEd1MElRS2hOOTRJc2hHOGxTSWl2X2JUZnBnc21kN1FqSWlBOERtcy1IYVROcnJ4UEhweUFRN0ZsVF9yNVM2TnVyZFowRVdFak5KQkJqSmZTMy1tZ1QycDFXdER6SFl2OHZtQUNvajlicjFkdTVxN1Z4d28tbw?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Declares Quarterly Cash Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNQ1RMRWdmY2FkallFQWpWYy1GMkE0MzZ1dVIzcEFOTm52SDVaUldTNU54ZjZwLXJNOVJFd20zeTR4R1g1ZmdYX0dKcFJvMDJXakgzS1RyNTdlYmJrQ0hXREpXMzJxWnB0R29KS0ZvRVg1bXdvaVU1czY2eklac3JBbDhXYWNERzBVNW5Nc3ZzOUFnMHRRbkxNcEJIN0JubF95VWN5MjVOSDhndw?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_gFBVV95cUxQRDZaS1ZUNEhZMnNxcGZzeW5zTGVzUFplSFA4VVpJUW1SOXZsX09UUW5jQkJEMWVrSVVFSGZUU1hLOUpwMXBTNkx4cG9iaUJtd2hhd0dxbGFOa0xkNUEtaWJ3bEdvcWd2RFJLY1NwbDdqUTc0WWFUSDdtYTh0ZkZuUHpOQWJ4U05Xa2tsMEs4cFZVajYxT19YczgzRWEwdGtmLWxFMWNTQ3oxTWVuT1FUakhyR19Vbmd2cGEtMVMxZHM3amJlYWcxS1hkYW0xcGNua1hzb09iMUxYVHpjU3FST085dWRGc1dHeUc5dXhoRjg5MWJvMVZkOUx4dWxZZw?oc=5", "source_name": "PR Newswire", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Investment Story For Quest Diagnostics (DGX) Is Quietly Shifting Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNMU5JeWttcFBpZk85Rl9kbXpYM1hKTWwwbXZwQ3g2Nm1Jamg5QldGMWxBUDJmdXJxbWRkUkpDY09HM3VDWGE3Y0pXMk4zVU9qX2NibHBESl9UZHdGYW52NkpnYVpfbHhmZkhFandpdGR2TGRhVndKRWVvenhxdmVfWjF1MXhCdTd0M3pxSDE4a0JKLWRZejU4RHJyN2x2QWdERlhLNmhR?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 104, "total_relevant": 64, "sentiment_summary": {"positive": 23, "negative": 2, "neutral": 39, "score": 55, "total": 64, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 19.55, "count": 33}, {"event": "earnings", "label": "Earnings", "weight": 8.8, "count": 16}, {"event": "analyst", "label": "Analyst action", "weight": 3.85, "count": 7}, {"event": "capital_return", "label": "Capital return", "weight": 1.65, "count": 3}, {"event": "macro", "label": "Macro sensitivity", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}], "positive_events": 23, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 210.68, "latest_week": "2026-07-17", "one_week_move": 1.6, "four_week_move": 8.5, "twelve_week_move": 7.3, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.834384, "market_dynamics_buy_signal": false, "relative_strength": 2.612741, "fair_value_gap": 33.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 55.5594, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.6% over one week, +8.5% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Ad-hoc-news.de", "count": 9}, {"label": "TradingView", "count": 9}, {"label": "Market source", "count": 6}, {"label": "PR Newswire", "count": 4}, {"label": "MarketWatch", "count": 3}, {"label": "Ad Hoc News", "count": 3}, {"label": "DirectorsTalk Interviews", "count": 3}, {"label": "Stock Titan", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 64}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 33}, {"label": "Earnings", "count": 16}, {"label": "Analyst action", "count": 7}, {"label": "Capital return", "count": 3}, {"label": "Macro sensitivity", "count": 2}, {"label": "Regulatory and legal", "count": 2}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "64", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+1.6% over one week, +8.5% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Quest Diagnostics stock trades steadily as investors weigh recent revenue growth and dividend income"}], "updated_at": "2026-07-21T21:36:09.957098+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}